Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.
…
continue reading
Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer. Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest ...
…
continue reading
Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology-oncology fellows ongoing access to the perspectives and opinions of national and international breast cancer clinical investigators.
…
continue reading
Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology/oncology fellows ongoing access to the perspectives and opinions of national and international research leaders with an expertise in thoracic oncology.
…
continue reading
![Artwork](/static/images/128pixel.png)
1
PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast
PVI, PeerView Institute for Medical Education
PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support ...
…
continue reading
Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.
…
continue reading
Designed for residents and fellows to provide an overview of the clinical practice and evidence behind management of each individual tumor site. Hematology/Oncology, evidence based medicine, education, chemotherapy, immunotherapy, cancer
…
continue reading
We quickly realized we knew very little about hematology and oncology when we started fellowship. Our goal is to bring you the fundamentals, core concepts and important management approaches in our field, driven by the latest evidence and expert opinion. In each episode, we will provide bite-sized, simplified approaches to common questions in a way that is perfect for anyone interested in hematology and oncology, from students and trainees to advanced practice providers and practicing physic ...
…
continue reading
The Blood Podcast summarizes content recently published in Blood, the most cited peer-reviewed publication in the field of hematology.
…
continue reading
![Artwork](/static/images/128pixel.png)
1
PeerView Oncology & Hematology CME/CNE/CPE Video Podcast
PVI, PeerView Institute for Medical Education
PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support ...
…
continue reading
Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is Chief of Clinical Trials, Professor of Cancer Research and Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Centre Tom Powles is Director of Barts Cancer Centre, St Bartholomews Hospital and Professor or Genitourinary oncology, Queen Mary University of London
…
continue reading
The Video Journal of Hematology and Hematological Oncology (VJHemOnc) podcast covers the latest hematological oncology and hematology news from international experts – from leukemias, lymphomas, MDS and MPNs, to sickle cell, aplastic anemia and rare diseases. Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion. If you enjoy the podcast, please leave us ...
…
continue reading
Oncology On The Go is a biweekly podcast that talks to authors and experts to thoroughly examine featured articles in the journal ONCOLOGY. Each episode, you'll hear from one of the authors of our featured article to summarize the important takeaways from that piece. Then, an outside expert will give their perspective on the details of that article. As the home of the journal ONCOLOGY, CancerNetwork offers different perspectives on oncology/hematology through review articles, news, podcasts, ...
…
continue reading
An academic platform for discussion of the latest and greatest updates in the ever evolving field of Medical Oncology and Clinical Hematology. Contact prashant.jambunathan@gmail.com
…
continue reading
learn bite-sized information about different aspects of hematology and oncology.
…
continue reading
The official podcast feed of MDedge Hematology-Oncology, part of the Medscape Professional Network. On Thursdays, Dr. David Henry interviews key opinion leaders and rising stars in hematology and oncology. The information in this podcast is provided for informational and educational purposes only.
…
continue reading
Interviews with experts on the top news and controversies in the field of oncology today.
…
continue reading
MedEdTalks Hematology is a continuing medical education podcast for physicians to allow them to learn while on the go and obtain CME credits. The intended audience for this series is hematologists, hematology nurses (RNs) and nurse practitioners (NPs), oncology RNs, oncology NPs, hemophilia treatment center RNs, hemophilia treatment center NPs, and other health care professionals.
…
continue reading
Dr RR Baliga's 'Got Knowledge Doc?' Podcasts for Physicians and Physician Extenders. Not medical advice or medical opinion www.MasterMedFacts.com
…
continue reading
Oncology and hematology
…
continue reading
Welcome to the Clinical Care Solutions Oncology podcast channel. Our podcast shows give you quick access to important content when you need it - at home, at your desk, or on the go.
…
continue reading
Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology/oncology fellows ongoing access to the perspectives and opinions of national and international research leaders with an expertise in renal cell carcinoma.
…
continue reading
Investigating HLH, brought to you by Sobi Inc., is a podcast that takes a deep dive into the complex world of hemophagocytic lymphohistiocytosis, or HLH. As a rare and fatal disease that was once considered incurable, HLH presents with a range of severe signs and symptoms that make diagnosis difficult. Join us as we discuss insights about HLH from all angles with various experts in the field of hematology-oncology who have helped to advance the understanding and treatment of this devastating ...
…
continue reading
Sundays @ 9:30am on KMA 960 AM - Shenandoah, IA
…
continue reading
![Artwork](/static/images/128pixel.png)
1
JOWMA (Jewish Orthodox Women's Medical Association) Podcast
JEWISH ORTHODOX WOMEN’S MEDICAL ASSOCIATION
Jennie Berkovich, DO and Alisa Minkin, MD host JOWMA's podcast and share preventative health information geared to members of the Orthodox Jewish community.
…
continue reading
Most people don’t know that you’re considered a cancer survivor at the moment of diagnosis. It wasn’t always this way. Sixty years ago, a cancer diagnosis was a death sentence. And if you did survive, you were left to figure out the rest of your life on your own. But some survivors demanded something different, something better. This is The Cancer Mavericks, a deep-dive narrative into the people who fought for better treatment, forced doctors to listen, and pushed America to see the human si ...
…
continue reading
Audio-reports and interviews done in collaboration with Audio Medica and its founding Editor Peter Goodwin. Audio Medica's Audio Journal of Oncology has been bringing lively listen-in shows to members of the cancer care team in various audio formats since 1992. Scientific Editors are George Canellos, MD, of Dana-Farber Cancer Institute; J. Gordon McVie, MD, of the European Institute of Oncology and Chair of the Editorial Board of OT's UK Edition; Pat Price, MD, of Christie Hospital, also on ...
…
continue reading
This is Sam and Karine, and we are Two Onc Docs! We both graduated from our Heme/Onc fellowships in 2021 and became board certified in both Hematology and Oncology. Our mission with Two Onc Docs is to create short board review episodes that you can listen to on your drive to work, while you make your morning coffee, or between pages on call. This is intended to be a supplement to other established board studying resources for busy trainees. *This podcast is intended to be an educational reso ...
…
continue reading
The Onco'Zine Brief is an interview and discussion program presented by Peter Hofland and covers a broad range of topics and timely news updates with information from all oncology disciplines and sub-specialties from around the world. The Onco'Zine Brief is a sponsor-supported, program for healthcare professionals involved in the management and care of cancer patients as well as cancer patients and their family and friends. If you like to join us as a sponsor or advertisers, download our med ...
…
continue reading
Welcome to Kars and Koaching, the podcast where we seamlessly blend our passion for cars, the intricacies of medicine, and the art of self-development to guide you towards the life you truly deserve. Join us on this unique journey as we explore the intersections of automotive excellence, healthcare insights, and personal growth. Get ready for engaging conversations, expert interviews, and practical tips that rev up your life both on and off the road. It's not just about driving, healing, or ...
…
continue reading
This book and subsequent audio companion reflect what I would have wanted when I was studying for the USMLE Step 2 CK exam. One of the major hurdles I faced while studying for my exam was the lack of a single reference resource similar to what existed for the USMLE Step 1 exam at the time of writing this book. This meant I had to use multiple resources which presented information in different formats and with different points of emphasis, resulting in a disorganized study approach. Despite m ...
…
continue reading
The Multiple Myeloma Research Foundation provides educational programs to help people with myeloma, family members, caregivers, and healthcare professionals learn more about the disease and today's most promising treatment options, including clinical trials, from leading multiple myeloma doctors and researchers.
…
continue reading
Frederick Health presents Coffee with Cookie: A Podcast Focused on Your Health & Happiness. Taking care of yourself, making healthy choices, and focusing on overall wellness can feel like a complex topic, but it doesn’t have to be. Join us as we take a deeper dive into the world of healthcare, disease prevention, wellness, and more. Brought to you by healthcare experts and providers that see patients right here in Frederick County. Frederick Health is simplifying the world of healthcare—beca ...
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Bradley J. Monk, MD, FACS, FACOG - Advancing Immunotherapy: Revolutionizing Cervical Cancer Treatment
35:53
35:53
Play later
Play later
Lists
Like
Liked
35:53
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/YQP865. CME/MOC cre…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Chapter 9: Hematology-Oncology - Miscellaneous Oncology
12:03
12:03
Play later
Play later
Lists
Like
Liked
12:03
We conclude this chapter discussing oncologic syndromes, paraneoplastic associations, and review of screening guidelines.By Abdillahi Omar, M.D.
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma
1:02:03
1:02:03
Play later
Play later
Lists
Like
Liked
1:02:03
Dr Jesús G Berdeja from the Greco-Hainsworth Tennessee Oncology Centers for Research in Nashville and Dr Thomas Martin from UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco discuss the most relevant new data sets and advances in multiple myeloma.By Neil Love, MD
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Specialty Spotlight: Rachel Offenbacher, MD, Pediatric Hematology/Oncology
26:07
26:07
Play later
Play later
Lists
Like
Liked
26:07
Rachel Offenbacher, MD is a Pediatric Hematologist/Oncologist at the Children’s Hospital at Montefiore (CHAM). She received her Medical Degree from SUNY Downstate after completing the Sophie Davis School of Biomedical Education (a 7 year BS/MD program at CUNY). She completed her residency and fellowship at CHAM and is an Assistanr Professor at the …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Breast Cancer from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
1:15:58
1:15:58
Play later
Play later
Lists
Like
Liked
1:15:58
Dr Priyanka Sharma from The University of Kansas Cancer Center in Westwood, Kansas, discusses recent advances in the treatment of breast cancer following the 2024 ASCO Annual Meeting.By Neil Love, MD
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Outcomes of younger patients with mantle cell lymphoma; M-protein assessment during maintenance therapy in multiple myeloma; in vivo CAR T-cell generation using lentiviral vectors
0:59
0:59
Play later
Play later
Lists
Like
Liked
0:59
In this week's episode we’ll discuss the outcomes of younger patients with mantle cell lymphoma experiencing late relapse; learn more about mass spectrometry-based assessment of M-protein in peripheral blood during maintenance therapy in multiple myeloma and discuss in vivo CAR T-cell generation in non-human primates using lentiviral vectors. Featu…
…
continue reading
Introduced by Associate Editor Dr. Thomas Ortel, this bonus episode discusses the Review Series on Factor XI, published in volume 143 issue 15 of Blood Journal. Dr. Ortel is joined by contributing authors Owen McCarty, PhD, Gili Kenet, MD, and David Gailani, MD. Review Series Articles: Introduction to a review series on factor XI Biology of factor …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The Needs of Gifted Students: Misdiagnosed & Misunderstood Exceptional Learners with Pessy Sloan, PhD
31:39
31:39
Play later
Play later
Lists
Like
Liked
31:39
Pessy J. Sloan is an Associate Professor in the College of Arts, Sciences and Education of Daemen University. Dr. Sloan earned her Ph.D. in Clinical and School Psychology from Hofstra University in 2000. She teaches graduate courses in both early childhood and childhood special education. Prior to joining Daemen University, Dr. Sloan held various t…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Bradley J. Monk, MD, FACS, FACOG - Advancing Immunotherapy: Revolutionizing Cervical Cancer Treatment
35:53
35:53
Play later
Play later
Lists
Like
Liked
35:53
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/YQP865. CME/MOC cre…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
ROS1-Alterations and Molecular Testing in Advanced NSCLC
16:28
16:28
Play later
Play later
Lists
Like
Liked
16:28
In this episode, listen to Alice T. Shaw, MD, PhD, and Jessica J. Lin, MD, share their thoughts on the current understanding of ROS1 rearrangements in non-small-cell lung cancer tumor biology and its implications for molecular testing and treatment selection including: ROS1-gene fusions in advanced lung cancer ROS1 testing recommendations with DNA …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Christopher L. Moertel, MD - Mapping a New Treatment Journey in NF1: New Developments With MEKi for Pediatric and Adult Patients With NF1-Plexiform Neurofibromas
37:22
37:22
Play later
Play later
Lists
Like
Liked
37:22
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/DET865. CME/AAPA c…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Christopher L. Moertel, MD - Mapping a New Treatment Journey in NF1: New Developments With MEKi for Pediatric and Adult Patients With NF1-Plexiform Neurofibromas
37:22
37:22
Play later
Play later
Lists
Like
Liked
37:22
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/DET865. CME/AAPA c…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 341: Hormone Resistance in Prostate Cancer
33:05
33:05
Play later
Play later
Lists
Like
Liked
33:05
Nima Sharifi joins Brian and Tom to discuss mechanisms of resistance to hormone therapy in prostate cancer
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Palliative Care x Dr. Janet Abrahm Part 1
27:44
27:44
Play later
Play later
Lists
Like
Liked
27:44
In Part 1 we discuss how to explain palliative care to patients, pain and anti-emetic management, non-pharmacologic strategies, and current innovations within palliative care. We are so honored to have Dr. Janet Abrahm here with us who is a national leader in the field of palliative care and a professor at Harvard Medical School.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
S1 Ep124: Afami-cel Approval May Open Gateway for Synovial Sarcoma Advancements
11:56
11:56
Play later
Play later
Lists
Like
Liked
11:56
In a conversation with CancerNetwork®, Brian A. Van Tine, MD, PhD, spoke about the FDA accelerated approval of afamitresgene autoleucel (afami-cel; Tecelra) for patients with metastatic or unresectable synovial sarcoma expressing MAGE-A4. He discussed the data from the phase 2 SPEARHEAD-1 trial (NCT04044768) supporting the agent’s use in this patie…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Oncology Today with Dr Neil Love: An interview with Professor Giuseppe Curigliano, MD, PhD — Management of Metastatic Breast Cancer
46:12
46:12
Play later
Play later
Lists
Like
Liked
46:12
Prof Giuseppe Curigliano from the European Institute of Oncology in Milano, Italy discusses current questions and controversies in the management of metastatic breast cancer.By Neil Love, MD
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Protective role of neonatal CMV infection in B-ALL; GVHD targets organoid-forming bile duct stem cells; seven-year outcomes for venetoclax-ibrutinib therapy in MCL
16:56
16:56
Play later
Play later
Lists
Like
Liked
16:56
In this week's episode we'll learn how cytomegalovirus infection early in life depletes preleukemic cells in a mouse model of B-cell acute lymphoblastic leukemia. After that we'll discuss new research, where GVHD targets organoid-forming bile duct stem cells in a TGF-beta-dependent manner. Conversely, a TGF-beta inhibitor protects these stem cells …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
From Fear to Freedom: Attacking Allergies with Zoya Treyster, MD
38:36
38:36
Play later
Play later
Lists
Like
Liked
38:36
Zoya Treyster, who is board-certified in both Pediatrics and Allergy/Immunology, works at Uptown Pediatrics in NYC. Dr. Treyster completed her undergraduate and medical school training at George Washington University, her pediatric residency at New York-Presbyterian Columbia, and her fellowship in Allergy/Immunology at Hofstra Northwell. Prior to j…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Chapter 10: Rheumatology - Crystalline Arthropathy
5:55
5:55
Play later
Play later
Lists
Like
Liked
5:55
A brief discussion of gout, pseudogout, and synovial fluid analysis.By Abdillahi Omar, M.D.
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Inside the Issue: Integrating ALK-Targeted Therapy into the Management of Localized Non-Small Cell Lung Cancer
1:01:23
1:01:23
Play later
Play later
Lists
Like
Liked
1:01:23
Prof Solange Peters from the Lausanne University Hospital in Lausanne, Switzerland, and Professor Ben Solomon from the Peter MacCallum Cancer Centre in Melbourne, Australia, discuss treatment approaches for ALK-rearranged non-small cell lung cancer in the localized disease setting.By Neil Love, MD
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 113: Sickle Cell Series - “Double Duty: A Doctor's Story of Living with Sickle Cell Disease While Caring for Others”
This week, we have an INCREDIBLE episode for you. We welcome Titilope Fasipe, MD, PhD, who not only is the Co-Director of the Sickle Cell and Thalassemia Program at Texas Children’s and an Assistant Professor in the Department of Pediatrics at the Baylor College of Medicine, she herself also has sickle cell disease! Dr. Fasipe takes us through her …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Chapter 10: Rheumatology - Seronegative Spondyloarthropathies
6:55
6:55
Play later
Play later
Lists
Like
Liked
6:55
Review of seronegative spondyloarthropathies.By Abdillahi Omar, M.D.
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Hemophilia updates from ISTH 2024: ongoing clinical trials, emerging gene therapies & remaining challenges
18:41
18:41
Play later
Play later
Lists
Like
Liked
18:41
This week's VJHemOnc podcast brings you updates in hemophilia from the 32nd Congress of the International Society on Thrombosis and Haemostasis (ISTH), held in Bangkok, Thailand, and virtually. You hear from experts Omolade Awodu, MBChB, MD, FMCPath, University of Benin, Benin City, Nigeria, who discusses key hemophilia clinical trials in 2024, Rad…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
S1 Ep123: Optimizing Benefits Following Dostarlimab Approval in Endometrial Cancer
10:56
10:56
Play later
Play later
Lists
Like
Liked
10:56
CancerNetwork® spoke with Ritu Salani, MD, about the expanded FDA approval of dostarlimab-gxly (Jemperli) in combination with carboplatin/paclitaxel for patients with primary advanced or recurrent endometrial cancer.1 Salani, a board-certified gynecologic oncologist and director of Gynecologic Oncology at the University of California, Los Angeles H…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 340: Cancer Immunity Cycle Update
41:50
41:50
Play later
Play later
Lists
Like
Liked
41:50
Ira Mellman delves into the update of this classic paper and the components of an effective anti-tumor immune response.
…
continue reading
This week’s episode will be repeating our episode on hemophilias with some updates. We will go over all high yield facts regarding both hemophilia A and B for your boards and end with a little bit about acquired hemophilias.
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Chapter 10: Rheumatology - Collagen Vascular Disease
28:20
28:20
Play later
Play later
Lists
Like
Liked
28:20
Extensive review of all things related to collagen vascular and autoimmune disease.By Abdillahi Omar, M.D.
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Oncology Today with Dr Neil Love: Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer
54:17
54:17
Play later
Play later
Lists
Like
Liked
54:17
Dr Sara A Hurvitz from the Fred Hutchinson Cancer Center in Seattle, Washington, summarizes recent trials investigating the integration of antibody-drug conjugates for HR-positive and triple-negative metastatic breast cancer.By Neil Love, MD
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Angela Lamarca, MD, PhD, MSc - Prioritising Patient-Centric Care in Biliary Tract Cancer: Leveraging Immunotherapy Platforms to Overcome Challenges in the Advanced Setting
22:50
22:50
Play later
Play later
Lists
Like
Liked
22:50
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/EUX865. CME credit will…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Angela Lamarca, MD, PhD, MSc - Prioritising Patient-Centric Care in Biliary Tract Cancer: Leveraging Immunotherapy Platforms to Overcome Challenges in the Advanced Setting
22:50
22:50
Play later
Play later
Lists
Like
Liked
22:50
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/EUX865. CME credit will…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Hussein Tawbi, MD, PhD - Renovating Frontline Care for Metastatic Melanoma: Guidance on Upgrading to Combination Immunotherapy Standards Across Disease Presentations
43:08
43:08
Play later
Play later
Lists
Like
Liked
43:08
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/RQT865. C…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Hussein Tawbi, MD, PhD - Renovating Frontline Care for Metastatic Melanoma: Guidance on Upgrading to Combination Immunotherapy Standards Across Disease Presentations
43:08
43:08
Play later
Play later
Lists
Like
Liked
43:08
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/RQT865. C…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Iron, HFE haemochromatosis, and infections; bispecific antibodies improve CAR T-cell response; determinants of outcome in NPM1-mutated AML
23:31
23:31
Play later
Play later
Lists
Like
Liked
23:31
In this week's episode we'll learn about iron, HFE hemochromatosis, and infections. In this large, population-based study, both high and low levels of plasma iron and transferrin saturation were associated with increased risks of infection. Then, we'll discuss how bispecific antibodies improve CAR T-cell response in B-cell malignancies. In-vitro an…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Myeloma Matters: Bispecific Antibody Horizons: Dosing Strategies and Meeting Updates in Myeloma Care
Host: Saad Z. Usmani, MD, MBA, FACP Guest: Joshua Richter, MD Guest: Ashley Steinberger, APP Release date: 8/15/2024 Expiration date: 8/15/2025 Estimated time to complete: 1.0 hour This activity is not accredited for CME/CE credit. This episode of Myeloma Matters reviews the latest data on bispecific antibody therapy for relapsed/refractory multipl…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
It Was Never About the Food: Intuitive Eating with Aliza Eisenstein, RDN
47:52
47:52
Play later
Play later
Lists
Like
Liked
47:52
Aliza Eisenstein is a Registered Dietitian/Nutritionist (RDN), licensed in the US and Israel, with close to 25 years of experience in health & nutrition. Aliza taught at Stern College before making aliyah in 2004. She managed the Special Diets department at the HASC Summer Program for 8 years. Aliza currently works in private practice, seeing clien…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Oncology Today with Dr Neil Love: Novel Agents and Strategies in Lung Cancer
1:01:43
1:01:43
Play later
Play later
Lists
Like
Liked
1:01:43
Dr Melissa Johnson from Sarah Cannon Research Institute in Nashville, Tennessee, Dr Ticiana Leal from Winship Cancer Institute of Emory University in Atlanta, Georgia, and Dr Manish Patel from Florida Cancer Specialists & Research Institute in Sarasota, Florida, summarize recently presented advancements, including novel strategies, in the treatment…
…
continue reading
In this week’s episode, we discuss the management of sickle cell disease in the chronic setting. This is a follow up to episode 111 where we discussed acute management of SCD. And furthermore, this is also in addition to our prior discussion about long-term chronic complications from SCD in episode 110. We highly recommend checking out these prior …
…
continue reading
Reviewing the different subtypes of lymphoma and their associations.By Abdillahi Omar, M.D.
…
continue reading
![Artwork](/static/images/128pixel.png)
1
ASCO 2024 Plenary: NADINA Trial Neoadjuvant Ipi/Nivo vs Adjuvant Nivo for Resectable Stage III Melanoma
10:09
10:09
Play later
Play later
Lists
Like
Liked
10:09
This week’s episode will be discussing updates from ASCO 2024 next with the practice changing NADINA trial presented on the Sunday of ASCO by Dr. Christian Blank during the plenary sessions: A multicenter, randomized, phase 3 trial comparing the efficacy of neoadjuvant ipilimumab plus nivolumab with standard adjuvant nivolumab in macroscopic resect…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Inflammation and immune interventions in MDS: targeting STAT, IRAK4, & more
17:29
17:29
Play later
Play later
Lists
Like
Liked
17:29
In myelodysplastic syndromes (MDS), chronic inflammation driven by the innate immune system plays a key role in disease progression. Signal Transducer and Activator of Transcription (STAT) and Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) are critical mediators in this process, where dysregulated signaling leads to aberrant hematopoiesis and t…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
S1 Ep122: Taking a “Cross-Cutting Approach” With Cancer Vaccinations
13:49
13:49
Play later
Play later
Lists
Like
Liked
13:49
In a conversation with CancerNetwork®, Catherine J. Wu, MD, spoke about the ongoing development of cancer vaccines as a potentially “cross-cutting” therapeutic strategy for treating patients with cancer. Wu, chief of the Division of Stem Cell Transplantation and Cellular Therapies and a Lavine Family Chair for Preventative Cancer Therapies at Dana-…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Chapter 9: Hematology-Oncology - Plasma Cell Dyscrasias
6:00
6:00
Play later
Play later
Lists
Like
Liked
6:00
A discussion on plasma cell dyscrasias primarily focused on Multiple Myeloma and Waldenström’s Macroglobulinemia.By Abdillahi Omar, M.D.
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 339: Tres Uramigas discuss ESMO guidelines for GU
18:37
18:37
Play later
Play later
Lists
Like
Liked
18:37
Maria, Christina and Elena discuss recent changes to the ESMO guidelines in kidney, bladder and prostate cancer.
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Chapter 9: Hematology-Oncology - Thrombocytosis
2:13
2:13
Play later
Play later
Lists
Like
Liked
2:13
A brief discussion on essential thrombocytosis and other causes of elevated platelet counts.By Abdillahi Omar, M.D.
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Immune fitness and response to taclistamab in R/R multiple myeloma; BCR::ABL1 M244V mutation causes resistance to asciminib; HSCT and myocardial fibrosis in young patients with SCD
16:59
16:59
Play later
Play later
Lists
Like
Liked
16:59
In this week's episode we’ll discuss how immune fitness impacts response to teclistamab in relapsed/refractory multiple myeloma; learn more about a new mechanism of resistance to asciminib conferred by the BCR::ABL1 M244V mutation, and discuss the impact of hematopoietic cell transplantation on myocardial fibrosis in young patients with sickle cell…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Individualizing the Selection of First-Line Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer
1:14:59
1:14:59
Play later
Play later
Lists
Like
Liked
1:14:59
Dr Joyce O’Shaughnessy from Sarah Cannon Research Institute in Dallas, Texas, summarizes risk factors and targeted therapy options for patients with HR-positive metastatic breast cancer.By Neil Love, MD
…
continue reading